Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark.
Int J Mol Sci. 2017 Dec 16;18(12):2738. doi: 10.3390/ijms18122738.
Cumulative lifetime ultraviolet radiation (UVR) is an important factor in the development of squamous cell carcinoma. This study examines the impact of UVR exposure pattern on tumor development. Hairless C3.Cg/TifBomTac immunocompetent pigmented mice ( = 351) were irradiated with 12 standard erythema doses (SED)/week, given as 2 SED ×6, 3 SED ×4, 4 SED ×3, or 6 SED ×2 (dose-delivery study) or 0, 0.6, 1.2, 2, 3 or 4 SED ×3/week (dose-response study). All mice were irradiated until development of 3 tumors of 4 mm each. Pigmentation was measured once monthly. In the dose-delivery study, the median time until tumor development was independent of dose fractions. In the dose-response study, higher UVR doses resulted in faster tumor appearance. When the weekly UVR dose was decreased from 12 to 6 SED, the cumulative UVR dose needed for tumor development was reduced by 40%. In conclusion, delivery schedules of a fixed weekly UVR dose did not affect tumor development. When using different weekly UVR doses, longer time to tumor development was observed using lower UVR doses. Lower weekly UVR doses however resulted in lower cumulative UVR doses to induce tumors in hairless pigmented mice.
累积终身紫外线辐射(UVR)是鳞状细胞癌发展的一个重要因素。本研究探讨了 UVR 暴露模式对肿瘤发展的影响。无毛 C3.Cg/TifBomTac 免疫功能正常的有色小鼠(=351)每周接受 12 个标准红斑剂量(SED)照射,每周 2SED×6、3SED×4、4SED×3 或 6SED×2(剂量传递研究)或每周 0、0.6、1.2、2、3 或 4SED×3(剂量反应研究)。所有小鼠均接受照射,直至每个肿瘤达到 4 毫米的 3 个肿瘤。每月测量一次色素沉着。在剂量传递研究中,肿瘤发展的中位时间与剂量无关。在剂量反应研究中,较高的 UVR 剂量导致肿瘤更快出现。当每周 UVR 剂量从 12 减少到 6SED 时,肿瘤发展所需的累积 UVR 剂量减少了 40%。总之,固定每周 UVR 剂量的剂量方案不会影响肿瘤的发展。当使用不同的每周 UVR 剂量时,使用较低的 UVR 剂量观察到肿瘤发展的时间更长。然而,较低的每周 UVR 剂量会导致诱导无毛有色小鼠肿瘤的累积 UVR 剂量降低。